Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Brandner

Showing results (241-250 of 369) with videos related to

Pageof 37
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2010
Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutationsCoro Paisán-Ruiz, Rocio Guevara, Monica Federoff, et al.
Journal of Biophotonics|January 20, 2022
Optical properties of human brain and tumour tissue: An ex vivo study spanning the visible range to beyond the second near-infrared windowJonathan Shapey, Yijing Xie, Elham Nabavi, et al.
The Cochrane Database of Systematic Reviews|March 12, 2021
Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomideAlexandra McAleenan, Claire Kelly, Francesca Spiga, et al.
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
The Cochrane Database of Systematic Reviews|March 2, 2022
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with gliomaAlexandra McAleenan, Hayley E Jones, Ashleigh Kernohan, et al.
Nature|June 11, 2015
A naturally occurring variant of the human prion protein completely prevents prion diseaseEmmanuel A Asante, Michelle Smidak, Andrew Grimshaw, et al.
Neuropathology and Applied Neurobiology|December 27, 2021
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic reviewSebastian Brandner, Alexandra McAleenan, Hayley E Jones, et al.
BMJ (Clinical Research Ed.)|October 17, 2013
Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale surveyO Noel Gill, Yvonne Spencer, Angela Richard-Loendt, et al.
Science (New York, N.Y.)|June 22, 2019
Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytesRoss Nortley, Nils Korte, Pablo Izquierdo, et al.
Nature Communications|April 15, 2022
Author Correction: The white matter is a pro-differentiative niche for glioblastomaLucy J Brooks, Melanie P Clements, Jemima J Burden, et al.
Pageof 37

Showing results (241-250 of 369) with videos related to

Sort By:
Pageof 37
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2010
Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutationsCoro Paisán-Ruiz, Rocio Guevara, Monica Federoff, et al.
Journal of Biophotonics|January 20, 2022
Optical properties of human brain and tumour tissue: An ex vivo study spanning the visible range to beyond the second near-infrared windowJonathan Shapey, Yijing Xie, Elham Nabavi, et al.
The Cochrane Database of Systematic Reviews|March 12, 2021
Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomideAlexandra McAleenan, Claire Kelly, Francesca Spiga, et al.
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
The Cochrane Database of Systematic Reviews|March 2, 2022
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with gliomaAlexandra McAleenan, Hayley E Jones, Ashleigh Kernohan, et al.
Nature|June 11, 2015
A naturally occurring variant of the human prion protein completely prevents prion diseaseEmmanuel A Asante, Michelle Smidak, Andrew Grimshaw, et al.
Neuropathology and Applied Neurobiology|December 27, 2021
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic reviewSebastian Brandner, Alexandra McAleenan, Hayley E Jones, et al.
BMJ (Clinical Research Ed.)|October 17, 2013
Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale surveyO Noel Gill, Yvonne Spencer, Angela Richard-Loendt, et al.
Science (New York, N.Y.)|June 22, 2019
Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytesRoss Nortley, Nils Korte, Pablo Izquierdo, et al.
Nature Communications|April 15, 2022
Author Correction: The white matter is a pro-differentiative niche for glioblastomaLucy J Brooks, Melanie P Clements, Jemima J Burden, et al.
Pageof 37